INTRAVENOUS IMMUNOGLOBULIN IN AUTOIMMUNE AND INFLAMMATORY DERMATOSES: A Review of Proposed Mechanisms of Action and Therapeutic Applications
- 1 July 2000
- journal article
- review article
- Published by Elsevier in Dermatologic Clinics
- Vol. 18 (3) , 447-457
- https://doi.org/10.1016/s0733-8635(05)70193-5
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Efficacy of intravenous immunoglobulins in sclerodermatomyositisBritish Journal of Dermatology, 2006
- Increased in vitro uptake of the complement C3b in the serum of patients with Guillain-Barré syndrome, myasthenia gravis and dermatomyositisJournal of Neuroimmunology, 1996
- Successful treatment of pemphigus vulgaris by pulsed intravenous immunoglobulin therapyBritish Journal of Dermatology, 1996
- Dramatic responses to intravenous immunoglobulin in vasculitis*Journal of Internal Medicine, 1995
- Adjuvant high-dose intravenous gammaglobulin in the treatment of pemphigus and bullous pemphigoid: experience in six patientsBritish Journal of Dermatology, 1995
- High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments.Journal of Clinical Investigation, 1994
- Anti‐Cytokine Nature of Natural Human Immunoglobulin: One Possible Mechanism of the Clinical Effect of Intravenous Immunoglobulin TherapyImmunological Reviews, 1994
- High-dose intravenous immunoglobulin modifies complement-mediated in vivo clearanceBlood, 1989
- Network Theory in AutoimmunityJournal of Clinical Investigation, 1981
- A Theoretical Model of γ-Globulin CatabolismNature, 1964